Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrahydrobiopterin and Folic Acid in CKD Exercise Intolerance
NCT01356966Phase 2Completed
- Sponsor
- Emory University
- Start
- May 2011
- Primary completion
- May 2014
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of sapropterin in chronic kidney disease (CKD), sponsored by Emory University. Started May 2011; status: completed.
02
Drugs
sapropterin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01356966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01356966.